Abstract PD1-05: Latest findings from the breast cancer cohort in SUMMIT - a phase 2 ‘basket’ trial of neratinib + trastuzumab + fulvestrant forHER2-mutant, hormone receptor-positive, metastatic breast cancer
Komal Jhaveri
◽
Cristina Saura
◽
Angel Guerrero-Zotano
◽
Iben Spanggaard
◽
François-Clement Bidard
◽
...